Heather McCoy
Adult Health · Scottsdale, AZNPI 1528190089
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $121,437 of the $156,051 with a category attached, or 77.8%. 35 manufacturers reported payments, led by AbbVie at 40.8% of the total. Reporting peaked in 2021 at $84,182 and has fallen 96.2% since, to $3,188 in 2025. Among adult health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 749 payments — averaging $208.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$64K
- Lilly USA, LLC$27K
- Teva Pharmaceuticals USA, Inc.$19K
- Amgen$16K
- Impel Pharmaceuticals Inc.$12K
- Lundbeck LLC$7K
- plus $12K from 29 others
What the payments were for
- Consulting fees$17,77011%
- Speaking & faculty fees$121,43778%
- Grants$850%
- Travel & lodging$4,7163%
- Food & beverage$11,9368%
- Education$1070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 240 | $63,628 |
| Lilly USA, LLC | 65 | $27,103 |
| Teva Pharmaceuticals USA, Inc. | 84 | $18,534 |
| Amgen | 41 | $15,822 |
| Impel Pharmaceuticals Inc. | 62 | $11,882 |
| Lundbeck LLC | 39 | $7,489 |
| Currax Pharmaceuticals LLC | 19 | $4,660 |
| Upsher-smith Laboratories LLC | 23 | $1,992 |
| Tonix Medicines, Inc. | 12 | $1,431 |
| Eli Lilly | 1 | $850 |
| Pfizer | 51 | $777 |
| Amneal Pharmaceuticals LLC | 21 | $329 |
| Acadia Pharmaceuticals Inc | 18 | $215 |
| MDD US Operations, LLC | 9 | $197 |
| Biohaven Pharmaceuticals, Inc. | 7 | $170 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $166 |
| Neurocrine Biosciences, Inc. | 7 | $158 |
| Abbott | 5 | $120 |
| Novartis | 8 | $112 |
| Scilex Pharmaceuticals Inc. | 5 | $99 |
| Collegium Pharmaceutical, Inc. | 3 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Almatica Pharma LLC | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| GE HealthCare | 1 | $25 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Boston Scientific | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Nevro Corp. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$156,051 in reported general payments places this provider in the 95th percentile of 314 adult health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 98 | $125,025 |
| Nurtec OdtRimegepant Sulfate | 40 | $101,938 |
| VyeptiEptinezumab-Jjmr | 21 | $86,421 |
| UbrelvyUbrogepant | 50 | $85,989 |
| Aimovig AutoinjectorErenumab-Aooe | 32 | $30,845 |
| Emgality SyringeGalcanezumab-Gnlm | 13 | $21,514 |
| Emgality PenGalcanezumab-Gnlm | 16 | $12,235 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 13 | $10,918 |
| Sumatriptan Succinate | 65 | $2,504 |
| Naratriptan Hcl | 71 | $2,256 |
| RizatriptanRizatriptan Benzoate | 52 | $1,395 |
| Topiramate | 36 | $1,350 |
| Gabapentin | 14 | $353 |
| Tizanidine Hcl | 23 | $305 |
| Dexamethasone | 47 | $274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta, Ubrelvy | $63,628 | $211,013148 claims |
| PfizerNurtec Odt | $777 | $101,93840 claims |
| Lundbeck LLCVyepti | $7,489 | $86,42121 claims |
| Upsher-smith Laboratories LLCTopiramate | $1,992 | $1,35036 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 314 adult health providers in Arizona.
Other adult health in Scottsdale
- Sherry DentonScottsdale$23K
- Leslie WojtowiczScottsdale$12K
- Melissa PrinceScottsdale$6K
- Joanne SchlesingerScottsdale$5K
- Lisa WilliamsScottsdale$3K
- Jennifer CollinsScottsdale$2K
- Ashleigh OrtegaScottsdale$2K
- Therese SargentPhoenix$307K
- Jennifer MylodGlendale$131K
- Natalie WilsonPhoenix$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.